Search For "us pharma"
Eli Lilly plans to invest over USD 1 billion in new contract manufacturing
Updated : 8 months, 1 week ago IST
In a major decision, US pharma giant Eli Lilly and Company (India) has said that it plans to invest more than $1 billion over the next several years into new contract manufacturing in India, expanding patients' access to innovative medicines aro
Read More
Trump's 100% tariff on patented drugs puts spotlight on India's USD 30 bil
Updated : 8 months, 1 week ago IST
The Indian pharmaceutical sector supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicines in the UK. According to a government release, drug and pharmaceutical exports increased by 6.94 per cent from USD 2.35
Read More
Trump's new executive orders may hit Indian Pharma exports, reshape global
Updated : 1 year, 1 month ago IST
The recent executive orders on pharma issued by President Donald Trump are expected to create significant challenges for Indian pharmaceutical companies, especially those operating in the U.S. generic drug market, according to a report by Nuvama Research.
Read More
Lawmakers express concerns over US pharma companies' involvement in clinic
Updated : 1 year, 9 months ago IST
Several lawmakers have urged the US Food and Drug Administration to initiate an investigation over US biopharmaceutical companies conducting clinical trials alongside the People's Liberation Army (PLA) in Xinjiang, a press release by The Select Committee on the Chinese Communist Party (SCCCP
Read More
COVID-19: J&J applies for approval to conduct clinical trials on adole
Updated : 4 years, 9 months ago IST
New Delhi [India], August 20 (ANI): US pharma giant Johnson & Johnson has moved an application before the Central Drugs Standard Control Organisation (CDSCO) in India, seeking permission to conduct clinical trials of its single-dose Janssen vaccine against COVID-19 on adolescents (chi
Read More
Johnson & Johnson's single-dose COVID-19 vaccine gets emergency use ap
Updated : 4 years, 10 months ago IST
New Delhi [India], August 7 (ANI): US pharma giant Johnson and Johnson's single-dose COVID-19 vaccine Janssen has received approval for Emergency Use Authorization (EUA) in India, informed Union Health Minister Mansukh Mandaviya on Saturday.
Read More
Johnson and Johnson applies for Emergency Use Authorization of its single-
Updated : 4 years, 10 months ago IST
New Delhi [India], August 6 (ANI): US pharma giant Johnson and Johnson on Friday said it has applied for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine Janssen to the Government of India.
Read More
India in talks with Johnson & Johnson for single-dose COVID-19 vaccine
Updated : 4 years, 11 months ago IST
New Delhi [India], July 2 (ANI): NITI Aayog member (Health) Dr VK Paul on Friday confirmed that India is in talks with US pharma giant Johnson & Johnson for their single-dose COVID-19 vaccine named Janssen.
Read More
Cipla seeks DCGI nod for import of Moderna's COVID-19 vaccine: Sources
Updated : 4 years, 11 months ago IST
New Delhi [India], June 29 (ANI): The Mumbai-based pharmaceutical multinational Cipla, on behalf of the US pharma major Moderna, has requested for import and marketing authorisation of its COVID-19 vaccines.
Read More
In final stages,' says Pfizer CEO on approval of its COVID vaccine in Indi
Updated : 4 years, 11 months ago IST
New Delhi [India], June 22 (ANI): US pharmaceutical major Pfizer's CEO Albert Bourla on Tuesday said the company is in the "final stages" of getting approval for its COVID-19 vaccine in India.
Read More
Pfizer in 'final stages' of getting approval for COVID-19 vaccine in India
Updated : 4 years, 11 months ago IST
New Delhi [India], June 22 (ANI): US pharmaceutical giant Pfizer on Tuesday said it is in the "final stages" of getting approval for its COVID-19 vaccine in India.
Read More
Japan to approve Pfizer COVID-19 vaccine for 12 to 15-year-olds
Updated : 5 years ago IST
Tokyo [Japan], May 30 (ANI): Japan health ministry panel has approved expanding the use of the US pharmaceutical-based COVID-19 vaccine - Pfizer - for people aged 12 to 15 in addition to those 16 or older.
Read More